Search research articles
Contact Us
Filters
Showing results (291-300 of 332) with videos related to
Page
of 34
Sort By:
International Journal of Molecular Sciences
|
April 12, 2018
Glucose-Dependent Insulinotropic Polypeptide Mitigates 6-OHDA-Induced Behavioral Impairments in Parkinsonian Rats
Yu-Wen Yu, Shih-Chang Hsueh, Jing-Huei Lai, et al.
Plos One
|
April 14, 2010
A synthetic uric acid analog accelerates cutaneous wound healing in mice
Srinivasulu Chigurupati, Mohamed R Mughal, Sic L Chan, et al.
ACS Pharmacology & Translational Science
|
April 16, 2021
<i>N</i>-Adamantyl Phthalimidine: A New Thalidomide-like Drug That Lacks Cereblon Binding and Mitigates Neuronal and Synaptic Loss, Neuroinflammation, and Behavioral Deficits in Traumatic Brain Injury and LPS Challenge
Shih Chang Hsueh, Weiming Luo, David Tweedie, et al.
Neurobiology of Disease
|
June 18, 2024
Corrigendum to "Pharmacokinetics and efficacy of PT302, a sustained-release Exenatide formulation, in a murine model of mild traumatic brain injury" [Neurobiology of Disease Volume 124 (2019) 439-453 /YNBDI_4338]
Miaad Bader, Yazhou Li, Daniela Lecca, et al.
Biomedicines
|
October 27, 2022
Activity of a Novel Anti-Inflammatory Agent F-3,6'-dithiopomalidomide as a Treatment for Traumatic Brain Injury
Shih Chang Hsueh, Michael T Scerba, David Tweedie, et al.
Neurobiology of Disease
|
November 25, 2018
Pharmacokinetics and efficacy of PT302, a sustained-release Exenatide formulation, in a murine model of mild traumatic brain injury
Miaad Bader, Yazhou Li, Daniela Lecca, et al.
Molecules (Basel, Switzerland)
|
December 5, 2020
Antiangiogenic Activity and in Silico Cereblon Binding Analysis of Novel Thalidomide Analogs
Megan L Peach, Shaunna L Beedie, Cindy H Chau, et al.
Journal of Alzheimer'S Disease : JAD
|
March 24, 2010
GLP-1 receptor stimulation reduces amyloid-beta peptide accumulation and cytotoxicity in cellular and animal models of Alzheimer's disease
Yazhou Li, Kara B Duffy, Mary Ann Ottinger, et al.
Journal of Biomedical Science
|
March 5, 2023
Novel, thalidomide-like, non-cereblon binding drug tetrafluorobornylphthalimide mitigates inflammation and brain injury
Daniela Lecca, Shih-Chang Hsueh, Weiming Luo, et al.
Healthcare (Basel, Switzerland)
|
November 14, 2023
Effect of Smartphone Use on Sleep in Undergraduate Medical Students: A Cross-Sectional Study
Ashish Goel, Arsalan Moinuddin, Rajesh Tiwari, et al.
Page
of 34
Search research articles
Search
Showing results (291-300 of 332) with videos related to
Sort By:
Page
of 34
International Journal of Molecular Sciences
|
April 12, 2018
Glucose-Dependent Insulinotropic Polypeptide Mitigates 6-OHDA-Induced Behavioral Impairments in Parkinsonian Rats
Yu-Wen Yu, Shih-Chang Hsueh, Jing-Huei Lai, et al.
Plos One
|
April 14, 2010
A synthetic uric acid analog accelerates cutaneous wound healing in mice
Srinivasulu Chigurupati, Mohamed R Mughal, Sic L Chan, et al.
ACS Pharmacology & Translational Science
|
April 16, 2021
<i>N</i>-Adamantyl Phthalimidine: A New Thalidomide-like Drug That Lacks Cereblon Binding and Mitigates Neuronal and Synaptic Loss, Neuroinflammation, and Behavioral Deficits in Traumatic Brain Injury and LPS Challenge
Shih Chang Hsueh, Weiming Luo, David Tweedie, et al.
Neurobiology of Disease
|
June 18, 2024
Corrigendum to "Pharmacokinetics and efficacy of PT302, a sustained-release Exenatide formulation, in a murine model of mild traumatic brain injury" [Neurobiology of Disease Volume 124 (2019) 439-453 /YNBDI_4338]
Miaad Bader, Yazhou Li, Daniela Lecca, et al.
Biomedicines
|
October 27, 2022
Activity of a Novel Anti-Inflammatory Agent F-3,6'-dithiopomalidomide as a Treatment for Traumatic Brain Injury
Shih Chang Hsueh, Michael T Scerba, David Tweedie, et al.
Neurobiology of Disease
|
November 25, 2018
Pharmacokinetics and efficacy of PT302, a sustained-release Exenatide formulation, in a murine model of mild traumatic brain injury
Miaad Bader, Yazhou Li, Daniela Lecca, et al.
Molecules (Basel, Switzerland)
|
December 5, 2020
Antiangiogenic Activity and in Silico Cereblon Binding Analysis of Novel Thalidomide Analogs
Megan L Peach, Shaunna L Beedie, Cindy H Chau, et al.
Journal of Alzheimer'S Disease : JAD
|
March 24, 2010
GLP-1 receptor stimulation reduces amyloid-beta peptide accumulation and cytotoxicity in cellular and animal models of Alzheimer's disease
Yazhou Li, Kara B Duffy, Mary Ann Ottinger, et al.
Journal of Biomedical Science
|
March 5, 2023
Novel, thalidomide-like, non-cereblon binding drug tetrafluorobornylphthalimide mitigates inflammation and brain injury
Daniela Lecca, Shih-Chang Hsueh, Weiming Luo, et al.
Healthcare (Basel, Switzerland)
|
November 14, 2023
Effect of Smartphone Use on Sleep in Undergraduate Medical Students: A Cross-Sectional Study
Ashish Goel, Arsalan Moinuddin, Rajesh Tiwari, et al.
Page
of 34